Drug class in one race
adenosine A2A drugs for Parkinson's Disease
2 tracked adenosine A2A drugs in the Parkinson's Disease race. The class explanation lives on the adenosine A2A page; the full indication pipeline across every mechanism is on the Parkinson's Disease page.
1 approved / phase 41 Phase 2/3
Head-to-head evidence: istradefylline vs VG081821AC